Human organic anion transporter 3 (hOAT3) is localized at the basolateral membrane of renal proximal tubule cells and facilitates the renal secretion of numerous clinical drugs, including anti-HIV therapeutics, anti-tumor drugs, antibiotics, antihypertension drugs and anti-inflammatories. The present study explored the role of serum and glucocorticoid-inducible kinase 1 (sgk1) in the regulation of hOAT3. It was shown that over-expression of sgk1 in hOAT3-expressing cells stimulated hOAT3 transport activity by enhancing the transporter expression at the plasma membrane, kinetically reflected as an increased maximal transport velocity V max without substantial change in the substrate-binding affinity K m . In contrast, treatment of cells with the sgk-specific inhibitor GSK650394 resulted in a dose-dependent inhibition of hOAT3 transport activity. Evidence was further provided that sgk1 regulation of hOAT3 activity was mediated by ubiquitin ligase Nedd4-2, an enzyme previously shown to have an inhibitory effect on hOAT3. It was shown that sgk1 phosphorylated Nedd4-2, weakened the association between Nedd4-2 and hOAT3, and decreased hOAT3 ubiquitination. Functionally, the sgk1-stimulated hOAT3 transport activity was attenuated in the presence of a ligase-dead mutant of Nedd4-2. In summary, the investigation established for the first time that sgk1 stimulates hOAT3 transport activity by interfering with the inhibitory effect of Nedd4-2 on the transporter. KEYWORDS drug transporter, organic anion transporter, regulation, serum and glucocorticoid-inducible kinase, ubiquitin ligase
| INTRODUCTION
The organic anion transporter (OAT) family consists of over ten membrane proteins. Organic anion transporter 3 (OAT3) is localized at the basolateral membrane of the renal proximal tubule cells and facilitates the renal secretion of numerous clinical drugs, including anti-HIV therapeutics, anti-tumor drugs, antibiotics, antihypertension drugs and anti-inflammatories (Ahn & Nigam, 2009; Dantzler & Wright, 2003; Srimaroeng, Perry, & Pritchard, 2008; Terada & Inui, 2007; VanWert, Gionfriddo, & Sweet, 2010; You, 2002) . We previously established that members of the OAT family are dynamic membrane transporters, constitutively internalizing from and recycling back to the plasma membrane. Alteration of the trafficking kinetics leads to a change in the amount of OAT at the plasma membrane and therefore leads to a change in OAT transport activity. For instance, the activation of protein kinase C (PKC) accelerates the rate of OAT endocytosis/internalization without changing the rate of OAT recycling (Zhang et al., 2008) .
Consequently, OAT expression at the plasma membrane is reduced and the OAT transport function is decreased.
Further studies from our laboratory demonstrated that PKC-stimulated OAT internalization requires the attachment of ubiquitin, a polypeptide of 76 amino acids, to OAT at the plasma membrane (Zhang, Li, Pattersom, & You, 2013) . The ubiquitin attached onto the transporter can be recognized by the internalization machinery and therefore triggers the internalization step. The ubiquitination of OAT is a reaction, catalysed by an E3 ubiquitin ligase Nedd4-2 (Xu, Wang, & You, 2016b; Xu, Wang, Zhang, & You, 2016c) . It was shown that Nedd4-2 inhibits OAT transport activity by enhancing OAT ubiquitination, and internalization, and therefore decreases OAT expression at the plasma membrane. Thus, Nedd4-2 is a significant regulator for OAT ubiquitination, expression and transport activity.
The serum-and glucocorticoid-inducible kinases (sgk) are a family of three serine/threonine kinase isoforms sgk1, sgk2 and sgk3. These kinases regulate various cellular processes such as sodium Na + balance, osmoregulation, cell survival and proliferation Chen et al., 1999; Leong, Maiyar, Kim, O'Keeffe, & Firestone, 2003; Naray-Fejes-Toth, Canessa, Cleaveland, Aldrich, & Fejes-Toth, 1999; Pao et al., 2010; Rozansky et al., 2002; Waldegger, Barth, Forrest, Greger, & Lang, 1998) . Their physiological roles in oncology, diabetes and obesity have also been discovered (Tessier & Woodgett, 2006) . Interestingly, there are distinct properties among sgk1, sgk2 and sgk3. Sgk1 and sgk3 are expressed ubiquitously, whereas sgk2 is limited to tissues such as liver, kidney, pancreas and brain. The expression of sgk1 and sgk3 in the kidney was regulated by aldosterone. In contrast, sgk2 is insensitive to such regulation. Our laboratory recently demonstrated that sgk2 plays a significant role in the regulation of OATs (Wang, Xu, Toh, Pao, & You, 2016; Xu et al., 2016a) .
However, the role of sgk1 in OAT function has not been explored.
In the current study, the critical role of the sgk1/Nedd4-2 signaling pathway in the transport function of hOAT3 was established.
| MATERIALS AND METHODS

| Materials
The COS-7 cells were purchased from ATCC (Manassas, VA). was generated in our laboratory by site-directed mutagenesis as described previously (Xu et al., 2016b , Xu et al., 2016c . cDNAs for mouse Flag-tagged sgk1s (wild-type sgk1, constitutively-active sgk1/ S422D and kinase-dead sgk/K127 M) were generously provided by Dr Alan C. Pao from the Department of Medicine, Stanford University, (Stanford, CA) . Brefeldin A and all other reagents were purchased from Sigma-Aldrich (St Louis, MO).
| Cell culture and transient transfection
Parental COS-7 cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Corning, Corning, NY) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY) at 37°C in 5% CO 2 . Lipofectamine 2000 (Invitrogen, Carlsbad, CA) was used for transfection of cDNAs following the manufacturer's instructions. Then 48 h after transfection, the cells were used for further experiments. For some experiments, the cells were starved with serum-free medium for 3-6 hours before experiments. Cells stably expressing hOAT3 were maintained in DMEM medium supplemented with 0.2 mg/ml G418 (Invitrogen, Carlsbad, CA), 10% fetal bovine serum.
| Transport measurements
The transport activity of hOAT3 was determined by measuring [ 
| Cell surface biotinylation
The expression level of hOAT3 at the cell surface was examined using a biotinylation strategy. The cells in monolayer culture were washed with ice-cold PBS and then incubated with 1 ml of NHS-SS-biotin (0.5 mg/ ml in PBS/CM) on ice for two consecutive 20 min periods under gentle shaking. Biotinylation was stopped by rinsing with 100 mM glycine in PBS/CM. Afterwards, the cell extracts were prepared in lysis buffer (10 mM Tris/HCl, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100 with 1/100 protease inhibitor cocktail and 20 mM Nethylmaleimide) for 30 min at 4°C and cleared by centrifugation at 16,000×g at 4°C. The supernatant was mixed with streptavidin-agarose beads (Pierce, Rockford, IL) to isolate cell surface proteins. Membraneexpressed hOAT3 was detected by SDS-PAGE and immunoblotting with an anti-myc antibody (epitope myc was tagged to hOAT3).
| Immunoprecipitation
The detailed procedure has been reported previously (Wang et al., 2016; Xu et al., 2016a) . The cells were lysed with lysis buffer and then precleared with protein G-agarose beads (Pierce, Rockford, IL) at 4°C for 2 h to reduce nonspecific binding. In the meantime, anti-myc antibody (1:100) was incubated with protein G-agarose beads at 4°C for 2 h. The precleared protein sample was then mixed with antibodybound protein G-agarose beads at 4°C overnight. On day 2, after washing with lysis buffer, immunoprecipitated proteins were eluted and immunoblotted with the indicated antibodies.
| Electrophoresis and immunoblotting
The protein samples were separated on 7.5% SDS-PAGE minigels 
| Data analysis
Each experiment was repeated at least three times. Student's paired t-tests were used to perform statistical analysis. A value of p < 0.05 was considered significant. In a separate experiment, hOAT3-expressing cells were treated with a sgk-selective inhibitor GSK650394, followed by the measurement of hOAT3-mediated uptake of [ 3 H] estrone sulfate.
GSK650394 induced a concentration-dependent inhibition with 40%
and 85% inhibition at concentrations of 100 nM and 1000 nM separately ( Figure 2 ).
The influence of sgk1 on the kinetic characteristics of hOAT3- The data represent uptake into hOAT3-transfected cells minus uptake into mock cells (parental COS-7 cells). The uptake activity was expressed as a percentage of the uptake measured in control cells.
Values are mean ± SE (n = 3) FIGURE 2 Sgk-specific inhibitor decreases hOAT3 transport activity. The COS-7 cells were co-transfected with hOAT3 and CAsgk1. Transfected cells were incubated with sgk-specific inhibitor GSK650394 for 30 min at indicated concentrations. A 3 min uptake of 
| Sgk1 enhances hOAT3 expression
The sgk1-induced increase in the maximal transport velocity V max of hOAT3 shown above (Figure 3 ) could either reflect an increased number of the transporters at the plasma membrane or an increased transporter turnover rate. To differentiate between these possibilities, the transporter expression was examined both at the plasma membrane and in total cell lysates. The results revealed that hOAT3 expressions at the cell surface (Figure 4a 
| Sgk1 stabilizes hOAT3
An increased expression of hOAT3 at the cell surface observed above (Figure 4a , top panel) may result from an enhanced insertion of the transporter into the plasma membrane or a decreased removal of the transporter from the plasma membrane. A reagent brefeldin A (BFA) was used to distinguish between these two mechanisms. BFA inhibits secretory mechanisms by blocking the transition of the transporters from the endoplasmic reticulum (ER) to Golgi, and preventing the formation of vesicles at the Golgi apparatus. As a result, insertion of the transporters into the plasma membrane is inhibited (Klaus et al., 2008) . As shown in Figure 5a , top panel, after a 6 h treatment with BFA, the decrease of hOAT3 expression at the plasma membrane was less dramatic in cells transfected with CA-sgk1 (65%) compared to Golgi, which led to the appearance of a 60 kDa band after BFA treatment. Therefore, the total expression of hOAT3 is the combination of the band at 60 kDa and the band at 80 kDa. It is important to note that even when the two bands (60 kDa + 80 kDa) were combined together, the intensity was still slightly lower than that without BFA treatment. The possible explanation is that BFA blocked the insertion of hOAT3 into the plasma membrane but did not block hOAT3 degradation. After the 6 h period, part of hOAT3 was removed from the plasma membrane and degraded. The degradation in the presence of sgk1 is slower than that without sgk1. Similarly, the decrease of hOAT3 transport activity was~61% in cells transfected with CAsgk1 compared with a more significant decline of~74% in control cells (Figure 5d ). These data suggest that sgk1 plays a significant role in stabilizing hOAT3 both at the plasma membrane and in total expression.
| Sgk1 phosphorylates Nedd4-2 in COS-7 cells
Previous investigations (Snyder, Olson, Kabra, Zhou, & Steines, 2004) in other systems reported that sgk1 regulates its substrates, at least in part, by phosphorylating Nedd4-2 at serine residue 327 (Ser 327).
The current experiment examined whether sgk1 also phosphorylated Nedd4-2 in this system. COS-7 cells were co-transfected with Nedd4-2 and control vector or with Nedd4-2 and CA-sgk1.
Phospho-Nedd4-2 was examined by immunoblotting with phosphorNedd4-2 (Ser327)-specific antibody. As shown in Figure 6a , the phospho-Nedd4-2-specific antibody recognized a band around the size of Nedd4-2 in control cells, indicating that Nedd4-2 was indeed 
| Sgk1 interferes with the interaction between Nedd4-2 and hOAT3
Our laboratory recently demonstrated (Xu et al., 2016b; Xu et al., 2016c ) that Nedd4-2, a ubiquitin ligase, binds to OAT and inhibits OAT transport activity by promoting the conjugation of ubiquitin to OAT, which leads to OAT internalization from the plasma membrane and subsequent degradation (Xu et al., 2016b; Xu et al., 2016c; and our unpublished results) . This experiment examined the relationship among sgk1, Nedd4-2 and hOAT3 using a co-immunoprecipitation strategy. As shown in Figure 7a , top panel, a significant amount of As shown in Figure 9 , sgk1 stimulated hOAT3 transport activity by 38% in control cells, presumably through interfering with the inhibitory effect of the endogenous Nedd4-2 on hOAT3. However, in cells transfected with a ligase-dead mutant of Nedd4-2 (Nedd4-2/ C821A), the stimulatory effect of sgk1 on hOAT3 was attenuated.
| DISCUSSION
Organic anion transporters (OATs) are major players in the efficacy and toxicity of therapeutic agents. Therefore, uncovering the molecular and cellular mechanisms for OAT regulation is clinically and Nedd4-2 ligase-dead mutant attenuates the stimulatory effect of CA-sgk1 on hOAT3 transport activity. The hOAT3-expressing COS-7 cells were transfected with sgk1 and control vector or with sgk1 and a ligase-dead mutant of Nedd4-2 (Nedd4-2/C821A). A 3 min uptake of [ 3 H]-estrone sulfate (0.3 μM) was then determined.
Uptake activity was expressed as a percentage of the uptake measured in cells without the transfection of sgk1. Values are mean ± SE (n = 3) pharmacologically significant. The current investigation revealed that the sgk1/Nedd4-2 signaling pathway plays a significant role in the regulation of hOAT3 function.
To carry out our investigation, monkey kidney COS-7 cells were chosen, a model cell system that has been used widely for mechanistic studies of many kidney transport processes. Importantly, the characteristic of OAT trafficking in COS-7 cells (Zhang, Suh, Pan, & You, 2012 ) is similar to that in rat kidney slices (Phatchawan, Chutima, Varanuj, & Anusorn, 2014) , where OATs are endogenously expressed.
Therefore, our studies in these cells will pave the path for the future exploration in assessing whether similar mechanisms are working in vivo. Secondly, sgk1 regulates hOAT3 function via ubiquitin ligase Nedd4-2. Sgk kinases were previously shown to modulate their targets by interacting with cytosolic components, one of which is the ubiquitin ligase Nedd4-2. Nedd4-2 is a key regulator of many membrane proteins such as sodium channel ENaC, potassium channel hERG and the amino acid transporter EAAT2 (Boehmer et al., 2006; Lamothe & Zhang, 2013; Snyder, Olson, & Thomas, 2002) . Our laboratory recently demonstrated (Xu et al., 2016b; Xu et al., 2016c ) that Nedd4-2 directly binds to OATs and catalyses the attachment of ubiquitin molecules to these transporters, which leads to the endocytosis/internalization of OATs from the plasma membrane to intracellular endosomes and subsequent degradation. Consequently, the amount of OATs at the plasma membrane is reduced and their transport activity is decreased (Xu et al., 2016b; Xu et al., 2016c; and our unpublished results) . In exploring the relationship among sgk1, Nedd4-2 and hOAT3, it was found that sgk1 phosphorylated Nedd4-2 ( Figure 6 ) weakened the interaction between Nedd4-2 and hOAT3 ( Figure 7 ) and decreased hOAT3 ubiquitination (Figure 8 ). The sgk1-induced phosphorylation of Nedd4-2 may cause a conformational change of the ubiquitin ligase, hinder its binding to hOAT3 and attenuate its inhibition of hOAT3 transport activity.
Therefore, the stimulatory effect of sgk1 on hOAT3 transport activity is due, in part, to the ability of sgk1 to interfere with the inhibitory effect of Nedd4-2 on hOAT3.
OATs are under the control of several protein kinases including protein kinase C (You, Kuze, Kohanski, Amsler, & Henderson, 2000) and sgk1 as demonstrated in our current study. These protein kinases exert their roles through phosphorylating their substrates. Our laboratory previously demonstrated that PKC regulates OAT activity by altering the trafficking kinetics of OATs without direct phosphorylation of the transporter itself (You et al., 2000; Zhang et al., 2008) . It is possible that PKC regulates OAT by phosphorylating an OAT-interacting partner. In our current study, it was shown that sgk1 phosphorylated Nedd-4-2 ( Figure 6 ). Whether sgk1 directly phosphorylates hOAT3 is an interesting topic for future investigation.
In summary, the current study demonstrated that hOAT3 activity is regulated through sgk1/Nedd4-2 signaling pathway. Sgk1 stimulated hOAT3 transport activity by interfering with the inhibitory effect of Nedd4-2 on the transporter. Sgk is the downstream signaling molecule for many physiological hormones such as glucocorticoids and mineralocorticoids (Hall, Kim, Skor, & Conzen, 2012; Pearce, 2001) .
Therefore, our current study provides important insights into how hOAT3-mediated drug elimination is regulated in vivo.
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